drugset / Trial / NCT01918735
A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of single ascending (increasing) and multiple doses of GWP42006 compared with placebo.
Timeline
- Start
- 2013-08
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidivarin | Small molecule | 25 mg | Oral |
| Subject | Cannabidivarin | Small molecule | 75 mg | Oral |
| Subject | Cannabidivarin | Small molecule | 200 mg | Oral |
| Subject | Cannabidivarin | Small molecule | 400 mg | Oral |